RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Dalcetrapib in Patients with Recent Acute Coronary Syndrome
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 18
SP 20
OP 21
DO 10.1177/155989771218011
UL http://mdc.sagepub.com/content/12/18/20.abstract
AB Observational studies have suggested that spontaneously higher high-density lipoprotein cholesterol (HDL-C) levels are associated with lower cardiovascular (CV) risk; however, it is uncertain whether raising HDL-C by a pharmacologic approach reduces the risk. The objective of the Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome [dal-OUTCOMES; NCT00658515; Schwartz GG et al. N Engl J Med 2012] was to compare the effects of dalcetrapib versus placebo in patients with recent acute coronary syndrome.